| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |